400 related articles for article (PubMed ID: 17378791)
41. Tissue oxygenation during management of cerebral perfusion pressure with phenylephrine or vasopressin.
Dudkiewicz M; Proctor KG
Crit Care Med; 2008 Sep; 36(9):2641-50. PubMed ID: 18679110
[TBL] [Abstract][Full Text] [Related]
42. [Vasodilatory septic shock refractory to catecholamines: is there a role for terlipressin?].
Fellahi JL; Bénard P; Daccache G; Mourgeon E; Gérard JL
Ann Fr Anesth Reanim; 2003 Jul; 22(7):631-4. PubMed ID: 12946495
[TBL] [Abstract][Full Text] [Related]
43. Employing dobutamine as a useful agent to reverse the terlipressin-linked impairments in cardiopulmonary hemodynamics and global oxygen transport in healthy and endotoxemic sheep.
Bröking K; Lange M; Morelli A; Ertmer C; Aken HV; Luecke M; Rehberg S; Böwering N; Bone HG; Traber DL; Westphal M
Shock; 2008 Jan; 29(1):71-7. PubMed ID: 17666952
[TBL] [Abstract][Full Text] [Related]
44. Terlipressin: vasopressin analog and novel drug for septic shock.
Pesaturo AB; Jennings HR; Voils SA
Ann Pharmacother; 2006 Dec; 40(12):2170-7. PubMed ID: 17148649
[TBL] [Abstract][Full Text] [Related]
45. Effects of terlipressin on systemic and regional haemodynamics in catecholamine-treated hyperkinetic septic shock.
Morelli A; Rocco M; Conti G; Orecchioni A; De Gaetano A; Cortese G; Coluzzi F; Vernaglione E; Pelaia P; Pietropaoli P
Intensive Care Med; 2004 Apr; 30(4):597-604. PubMed ID: 14673520
[TBL] [Abstract][Full Text] [Related]
46. Terlipressin as rescue therapy for intractable hypotension during neonatal septic shock.
Matok I; Leibovitch L; Vardi A; Adam M; Rubinshtein M; Barzilay Z; Paret G
Pediatr Crit Care Med; 2004 Mar; 5(2):116-8. PubMed ID: 14987339
[TBL] [Abstract][Full Text] [Related]
47. Use of methylene blue for refractory septic shock during continuous venovenous hemodiafiltration.
Mount JC; Rowe AS
Pharmacotherapy; 2010 Mar; 30(3):323. PubMed ID: 20180614
[TBL] [Abstract][Full Text] [Related]
48. Cerebral perfusion pressure: management protocol and clinical results.
Rosner MJ; Rosner SD; Johnson AH
J Neurosurg; 1995 Dec; 83(6):949-62. PubMed ID: 7490638
[TBL] [Abstract][Full Text] [Related]
49. Vasopressin and terlipressin in adult vasodilatory shock: a systematic review and meta-analysis of nine randomized controlled trials.
Serpa Neto A; Nassar AP; Cardoso SO; Manetta JA; Pereira VG; Espósito DC; Damasceno MC; Russell JA
Crit Care; 2012 Aug; 16(4):R154. PubMed ID: 22889256
[TBL] [Abstract][Full Text] [Related]
50. Severe head injury: control of physiological variables, organ failure and complications in the intensive care unit.
Schirmer-Mikalsen K; Vik A; Gisvold SE; Skandsen T; Hynne H; Klepstad P
Acta Anaesthesiol Scand; 2007 Oct; 51(9):1194-201. PubMed ID: 17711565
[TBL] [Abstract][Full Text] [Related]
51. Terlipressin versus norepinephrine to correct refractory arterial hypotension after general anesthesia in patients chronically treated with renin-angiotensin system inhibitors.
Boccara G; Ouattara A; Godet G; Dufresne E; Bertrand M; Riou B; Coriat P
Anesthesiology; 2003 Jun; 98(6):1338-44. PubMed ID: 12766641
[TBL] [Abstract][Full Text] [Related]
52. An open label, pilot, randomized controlled trial of noradrenaline versus terlipressin in the treatment of type 1 hepatorenal syndrome and predictors of response.
Sharma P; Kumar A; Shrama BC; Sarin SK
Am J Gastroenterol; 2008 Jul; 103(7):1689-97. PubMed ID: 18557715
[TBL] [Abstract][Full Text] [Related]
53. Vasopressor agents in shock.
Moyer JH; Mills LC
Am J Nurs; 1975 Apr; 75(4):620-5. PubMed ID: 1039254
[TBL] [Abstract][Full Text] [Related]
54. Severe ischemia of the lower limb and of the intestine associated with systemic vasoconstrictor therapy and femoral arterial catheterization.
Borrego R; López-Herce J; Mencía S; Carrillo A; Sancho L; Bustinza A
Pediatr Crit Care Med; 2006 May; 7(3):267-9. PubMed ID: 16575352
[TBL] [Abstract][Full Text] [Related]
55. Role of terlipressin in the treatment of infants and neonates with catecholamine-resistant septic shock.
Leone M; Martin C
Best Pract Res Clin Anaesthesiol; 2008 Jun; 22(2):323-33. PubMed ID: 18683478
[TBL] [Abstract][Full Text] [Related]
56. Terlipressin as rescue therapy for refractory pulmonary hypertension in a neonate with a congenital diaphragmatic hernia.
Stathopoulos L; Nicaise C; Michel F; Thomachot L; Merrot T; Lagier P; Martin C
J Pediatr Surg; 2011 Feb; 46(2):e19-21. PubMed ID: 21292065
[TBL] [Abstract][Full Text] [Related]
57. To drink or not to drink: The role of fluid versus vasopressor resuscitation in traumatic brain injury and systemic inflammatory response syndrome.
Huh JW; Helfaer MA
Crit Care Med; 2006 Oct; 34(10):2697-8. PubMed ID: 16983278
[No Abstract] [Full Text] [Related]
58. Hemodynamic effects of terlipressin (a synthetic analog of vasopressin) in healthy and endotoxemic sheep.
Scharte M; Meyer J; Van Aken H; Bone HG
Crit Care Med; 2001 Sep; 29(9):1756-60. PubMed ID: 11546979
[TBL] [Abstract][Full Text] [Related]
59. Terlipressin versus norepinephrine to counteract anesthesia-induced hypotension in patients treated with renin-angiotensin system inhibitors: effects on systemic and regional hemodynamics.
Morelli A; Tritapepe L; Rocco M; Conti G; Orecchioni A; De Gaetano A; Picchini U; Pelaia P; Reale C; Pietropaoli P
Anesthesiology; 2005 Jan; 102(1):12-9. PubMed ID: 15618781
[TBL] [Abstract][Full Text] [Related]
60. Hemodynamic manipulation in the neuro-intensive care unit: cerebral perfusion pressure therapy in head injury and hemodynamic augmentation for cerebral vasospasm.
Diringer MN; Axelrod Y
Curr Opin Crit Care; 2007 Apr; 13(2):156-62. PubMed ID: 17327736
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
